Amgen Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
And there we are. We're live, unceremoniously like that. Well, my name is Evan Seigerman. I'm the senior large-cap biopharma analyst here at Crédit Suisse. And it's my pleasure to introduce Amgen on the first day of our Virtual Healthcare Conference. I'm looking forward to next year when we can all be in person. We were reminiscing about how nice that was. But from Amgen, we have Peter Griffith, CFO; Murdo Gordon, Global Commercial Operations; and of course, Arvind Sood, VP of IR.
I was told very specifically to give it to Arvind after the introduction. So Arvind, take it away.
Evan, thank you very much. Good afternoon, everybody. I really appreciate this opportunity. As you mentioned, Evan, we would much rather be at The Phoenician in Scottsdale, but that's kind of the way it is right now.
So Evan, let me just tee up some key topics, and then we can move on to your questions. Our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
